Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P548: Hepatitis B virus reactivation in hepatitis B virus infected patients with inflammatory bowel disease receiving anti-tumor necrosis factor-alpha therapyECCO '17 Barcelona
Year: 2017
Authors:

Lee J.M.*1, Lee K.-M.1, Kim H.-S.2, Ye B.D.3, Park S.J.4, Park S.H.3, Im J.P.5, Jang B.I.6, Kim D.B.1

1The Catholic University of Korea, School of Medicine, St. Vincent's Hospital, Suwon, South Korea 2Yonsei University Wonju College of Medicine, Wonju, South Korea 3Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea 4Yonsei University College of Medicine, Seoul, South Korea 5Seoul National University College of Medicine, Seoul, South Korea 6Yeungnam University College of Medicine, Daegu, South Korea

P549: Effect of maintenance Ustekinumab on corticosteroid-free clinical outcomes in patients with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Feagan B.G.*1, Gasink C.2, Pollack P.2, Jacobstein D.2, Gao L.-L.2, Johanns J.2, Miao Y.2, Targan S.3, Ghosh S.4

1Robarts Clinical Trials, Robarts Research Institute, Western University, London, Ont., Canada 2Janssen Research & Development, LLC, Spring House, United States 3Cedars-Sinai Medical Center, Los Angeles, United States 4University of Birmingham, Birmingham, United Kingdom

P550: Clinical features of demyelination following anti-TNFα therapyECCO '17 Barcelona
Year: 2017
Authors:

Hendy P.1,2, Heerasing N.*1,2, Walker G.2, Heap G.1,2, Bewshae C.2, Kennedy N.1, Goodhand J.1, Martin R.3, Hobart J.4, Harrower T.5, Coles A.6, Ahmad T.1,2

1Royal Devon & Exeter NHS Foundation Trust, Department of Gastroenterology, Exeter, United Kingdom 2Royal Devon & Exeter NHS Foundation Trust, IBD Pharmacogenetics Research, Exeter, United Kingdom 3Gloucestershire Royal Hospital, Department of Neurology, Gloucester, United Kingdom 4Plymouth University, Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom 5Royal Devon & Exeter NHS Foundation Trust, Department of Neurology, Exeter, United Kingdom 6Addenbrooke's Hospital, Department of Neurosciences, Cambridge, United Kingdom

P551: Smooth Seton® for perianal fistulas: a knot-less solutionECCO '17 Barcelona
Year: 2017
Authors:

Stellingwerf M.*1, de Groof J.1, Buskens C.1, Nerkens W.2, Horeman T.2, Bemelman W.1

1AMC, Surgery, Amsterdam, Netherlands 2MediShield B.V., Delft, Netherlands

P552: An online educational portal improves concerns of inflammatory bowel disease patients regarding pregnancy and medicationECCO '17 Barcelona
Year: 2017
Authors:

Sutton R.1, Wierstra K.2, Ambrosio L.3, Dieleman L.3, Fedorak R.N.3, Halloran B.3, Kroeker K.I.3, Wong K.3, Berga K.-A.4, Huang V.W.*5

1University of Alberta, Department of Medicine, Edmonton, Canada 2University of Alberta, Edmonton, Canada 3University of Alberta, Gastroenterology, Edmonton, Canada 4MacEwan University, Edmonton, Canada 5University of Alberta, Medicine, Edmonton, Canada

P553: Long-term outcomes of seton drainage for perianal fistulizing Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Banayan E., Zagihyan K., Fleshner P.

Cedars-Sinai Medical Center, Colorectal Surgery, Los Angeles, United States

P554: Impact of real world home based remote monitoring on quality of care and quality of life in inflammatory bowel disease patients: one year results of pragmatic randomized trialECCO '17 Barcelona
Year: 2017
Authors:

Atreja A., Khan S., Otobo E., Rogers J., Ullman T., Grinspan A., Itzkowitz S., Maser E., Cohen B., Colombel J.-F., Sands B.

Icahn School of Medicine at Mount Sinai, Department of Medicine, New York City, United States

P555: Systematic review of interventions for chronic abdominal pain management in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Norton C.1, Czuber-Dochan W.2, Artom M.2, Sweeney L.*2, Hart A.3

1King's College, Faculty of Nursing and Midwifery, London, United Kingdom 2King's College London, Faculty of Nursing and Midwifery, London, United Kingdom 3St Marks Hospital, Gastroentrology, London, United Kingdom

P556: Female Crohn's disease patients and ulcerative colitis patients on biologic therapy are most disabledECCO '17 Barcelona
Year: 2017
Authors:

Spizzo P.

St Vincent's Hospital Melbourne, Victoria, Australia

P557: Utility of “trough levels” adalimumab determination in patients with inflammatory bowel disease. Estimation of individual pharmacokinetic parameters through population pharmacokinetic modelECCO '17 Barcelona
Year: 2017
Authors:

Juan G.*1, Alvariño A.2, Mora M.3, Oltra L.3, Maroto N.3, Ferrer I.3, Hinojosa E.3, Hinojosa M.D.3, Hinojosa J.3

1Hospital de Manises, Department of Pharmacy, Manises, Spain 2Hospital de Manises, Department of Labratory, Manises, Spain 3Hospital de Manises, IBD Unit, Manises, Spain

P558: The SF-36® Health Survey distinguishes disease burden on functioning and well-being between patients with active vs inactive ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Rubin D.T.*1, Panés J.2, Lindsay J.O.3, Vermeire S.4, Yarlas A.5, Bayliss M.5, Cappelleri J.C.6, Maher S.5, Bushmakin A.G.6, Chen L.A.7, Manuchehri A.8, Healey P.6

1The University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, United States 2Hospital Clinic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain 3Centre for Immunobiology, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom 4Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium 5Optum, Lincoln, RI, United States 6Pfizer Inc, Groton, CT, United States 7New York University School of Medicine, New York, NY, United States 8Pfizer Ltd, Tadworth, United Kingdom

P559: Treatment goals in IBD: a perspective from patients and their partnersECCO '17 Barcelona
Year: 2017
Authors:

Peek-Kuijt N., Aantjes M., Verwey M., van der Meulen-de Jong A., Maljaars P.

Leiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands

P560: Trough levels at induction: impact on long term response when re-initiating infliximabECCO '17 Barcelona
Year: 2017
Authors:

Liefferinckx C.*1, Minsart C.2, Toubeau J.-F.3, Cremer A.4, Amininejad L.4, Quertinmont E.2, Devière J.4, Gils A.5, Van Gossum A.4, Franchimont D.4

1Université libre de bruxelles, Laboratory of Experimental Gastroenterology, Brussels, Belgium 2Université libre de Bruxelles, Laboratory of Experimental Gastroenterology, Brussels, Belgium 3Université de Mons, Department of Electrical Engineering, Mons, Belgium 4Erasme Hospital, Gastro-enterology, Brussels, Belgium 5KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium

P561: Can we predict adherence to treatment in IBD patients?ECCO '17 Barcelona
Year: 2017
Authors:

Naftali T.*1, Ein Dor A.2,3, Ruhimovich N.4, Shitrit A.B.5, Sklerovsky Benjaminov F.2,4, Matalon S.2,3, Shirin H.3,6, Konikoff F.M.1,2, Broide E.3,6

1Meir medical center, Gastroenterology, Kfar Saba, Israel 2Tel Aviv university Sackler school of medicin, internal medicine, Tel Aviv, Israel 3Assaf Harofeh Medical Center, The Kamila Gonczarowski institute of Gastroenterology Assaf Harofeh Medical Center, Zerifin, Israel 4Meir Medical Center, Department of Gastroenterology & Hepatology, Kfar Saba, Israel 5Shaare Zedek Medical Center, Department of Gastroenterology and Digestive Diseases, Jerusalem, Israel 6Tel Aviv university Sackler school of medicin, internal medicine, Tel aviv, Israel

P562: Real-life infliximab trough levels among inflammatory bowel disease patients on maintenance therapy: should we redefine therapeutic range based on inflammatory load?ECCO '17 Barcelona
Year: 2017
Authors:

Lobaton T.*1, Cañete F.1, Teniente A.2, Cabre E.1,3, Mañosa M.1, Martínez E.2, Domènech E.1,3

1University Hospital Germans Trias i Pujol, Gastroenterology, Badalona (Barcelona), Spain 2University Hospital Germans Trias i Pujol, Immunology, Badalona (Barcelona), Spain 3CIBER, Badalona (Barcelona), Spain

P563: Psychotherapy experience and demand for it and their association in inflammatory bowel disease – results from an internet-based surveyECCO '17 Barcelona
Year: 2017
Authors:

Klag T.*1, Mazurak N.2, Fantasia L.1, Schwille-Kiuntke J.2, Kirschniak A.3, Goetz M.1, Malek N.1, Enck P.2, Wehkamp J.1

1University Hospital Tuebingen, Internal Medicine I, Tuebingen, Germany 2University Hospital Tuebingen, Internal Medicine VI, Tuebingen, Germany 3University Hospital Tuebingen, General Surgery, Tuebingen, Germany

P564: Low-dose azathioprine improves long-term efficacy of infliximab maintenance treatment in Japanese patients with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Nasuno M.*1, Motoya S.1, Sugiyama K.1, Miyakawa M.1, Tanaka H.1, Iida T.2, Onodera K.2, Nakase H.2

1Sapporo Kosei General Hospital, IBD Center, Sapporo, Japan 2Sapporo Medical University, School of Medicine, Department of Gastroenterology and Hepatology, Sapporo, Japan

P565: Assessments of clinical efficacy and mucosal healing in ulcerative colitis patients undergoing granulomonocytapheresis at different treatment frequenciesECCO '17 Barcelona
Year: 2017
Authors:

Ohmori T., Ohmori S.

Ohmori Toshihide GastroIntestinal Clinic, Ageo, Japan

P566: Frequency and type of drug-related side effects necessitating drug cessation in the Swiss inflammatory bowel disease cohortECCO '17 Barcelona
Year: 2017
Authors:

Godat S.*1, Fournier N.2, Safroneeva E.3, Marot A.1, Deltenre P.1, Hahnloser D.4, Straumann A.5, Vavricka S.6, Biedermann L.7, Rogler G.8, Schoepfer A.1

1CHUV - Centre Hospitalier Universitaire Vaudois, Department of Gastroenterology and Hepatology, Lausanne, Switzerland 2University of Lausanne, Institute of Social and Preventive Medicine, Lausanne, Switzerland 3University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland 4Centre Hospitalier Universitaire Vaudois CHUV, Department of Visceral Surgery, Lausanne, Switzerland 5Swiss EoE Center, Praxis Roemerhof, Olten, Switzerland 6Stadtspital Triemli, Department of Gastroenterology and Hepatology, Zurich, Switzerland 7University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland 8University Hospital Zürich, Department of Gastroenterology and Hepatology, Zurich, Switzerland

P567: Cross-sectional study of the low serum concentrations of testosterone in IBD and the influence on disease activityECCO '17 Barcelona
Year: 2017
Authors:

Hlavaty T., Krajcovicova A., Kollerova J., Koller T., Leskova Z., Sturdik I., Payer J.

Comenius University, Faculty of Medicine and University Hospital Bratislava, 5th Department of Internal Medicine, Bratislava, Slovakia